Drugs / MG1109
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01389466 | Feb 2010 → Nov 2011 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01987011 | Aug → Oct 2013 | influenza | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MG1109 | “MG1109 is purified, inactivated influenza viral antigen.” NCT01389466 ↗ |
| Modality | Vaccine | “investigational vaccine” NCT01389466 ↗ |
| Route | Intramuscular | “intramuscularly injection” NCT01389466 ↗ |